NCT07346534

Brief Summary

Study Description This prospective, controlled clinical study aims to compare the clinical outcomes of reinforced anastomosis using 8-10 interrupted sutures versus the conventional Dixon procedure in patients undergoing laparoscopic low anterior resection for low rectal cancer. Anastomotic leakage remains one of the most significant postoperative complications following low rectal cancer surgery, particularly in laparoscopic procedures due to limited tactile feedback and maneuverability in the pelvic cavity. Reinforcement of the anastomotic site through additional interrupted suturing may provide better mechanical strength and improved healing, potentially reducing the incidence of anastomotic leakage and related morbidities. In this study, eligible patients will be assigned to receive either a conventional laparoscopic Dixon procedure or the same procedure with added reinforcement of the anastomosis using 8-10 interrupted sutures circumferentially. Perioperative outcomes including the rate of anastomotic leakage, postoperative complications, operation time, length of hospital stay, return of bowel function, and quality of life will be assessed and compared between the two groups. The study seeks to provide evidence for optimizing surgical techniques in low rectal cancer treatment and improving patient prognosis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jun 2022Dec 2026

Study Start

First participant enrolled

June 1, 2022

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

4.6 years

First QC Date

July 16, 2025

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Anastomotic Leakage

    Defined as clinically significant leakage confirmed by radiological or surgical evidence, classified according to International Study Group of Rectal Cancer (ISREC) criteria.

    Within 30 days postoperatively

Secondary Outcomes (3)

  • Postoperative Complication Rate

    Up to 30 days after surgery

  • Operation Time

    During the surgical procedure

  • Length of Postoperative Hospital Stay

    From date of surgery through date of discharge, up to 30 days

Study Arms (2)

Reinforced Anastomosis with 8-10 Interrupted Sutures

EXPERIMENTAL

Patients in this group will undergo laparoscopic low anterior resection (Dixon procedure) for low rectal cancer, followed by reinforcement of the anastomosis using 8-10 interrupted seromuscular sutures circumferentially around the stapled anastomotic site. The reinforcement is intended to enhance anastomotic integrity and reduce the risk of leakage.

Procedure: Reinforced Anastomotic Suturing (8-10 Interrupted Sutures)

Conventional Dixon Procedure

ACTIVE COMPARATOR

Patients in this group will undergo standard laparoscopic low anterior resection (Dixon procedure) for low rectal cancer without additional reinforcement of the anastomosis. The anastomosis will be performed using a circular stapler alone, as per conventional practice.

Procedure: Conventional Laparoscopic Dixon Procedure

Interventions

After completing the laparoscopic low anterior resection (Dixon procedure) for low rectal cancer, the surgeon performs additional reinforcement of the colorectal anastomosis. This is done by placing 8 to 10 interrupted seromuscular sutures circumferentially around the anastomotic site. The goal of this reinforcement is to enhance anastomotic stability, promote healing, and reduce the risk of anastomotic leakage.

Reinforced Anastomosis with 8-10 Interrupted Sutures

Patients undergo standard laparoscopic low anterior resection (Dixon procedure) for low rectal cancer. The colorectal anastomosis is performed using a circular stapler without any additional suturing or reinforcement. This represents the conventional surgical approach widely used in clinical practice.

Conventional Dixon Procedure

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 85 years.
  • Diagnosed with low rectal adenocarcinoma located within 7 cm from the anal verge by colonoscopy and biopsy.
  • Scheduled for elective laparoscopic low anterior resection (Dixon procedure).
  • Clinical stage I-III (based on preoperative imaging, e.g., MRI/CT) without distant metastasis.
  • Adequate organ function (hematologic, hepatic, renal) to tolerate surgery.
  • Provided written informed consent and willing to comply with study procedures and follow-up.

You may not qualify if:

  • Presence of synchronous distant metastases or other malignancies.
  • History of prior pelvic radiotherapy or major pelvic surgery.
  • Severe uncontrolled comorbidities (e.g., severe cardiovascular, respiratory, hepatic or renal insufficiency).
  • Emergency surgery indication (e.g., bowel obstruction, perforation).
  • Pregnancy or breastfeeding.
  • Known allergy or contraindication to anesthesia or surgical materials used.
  • Participation in another interventional clinical trial within the last 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tenth People's Hospital

Shanghai, China

Location

MeSH Terms

Conditions

Rectal NeoplasmsColorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesColonic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator assistant

Study Record Dates

First Submitted

July 16, 2025

First Posted

January 16, 2026

Study Start

June 1, 2022

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations